Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on dynamic kinetic resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104263803A details high-purity S-2-tetrahydronaphthalene amine synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104263799A enables high-purity S-2-tetrahydronaphthylamine via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN114621985B reveals enzymatic synthesis breakthrough. Delivers high purity and supply chain reliability for global pharmaceutical intermediate procurement strategies.
Patent CN104263802B enables high-purity S-1-tetrahydronaphthalene amines via dynamic kinetic resolution, ensuring supply chain reliability.
Patent CN104152527A details DKR method for R-2-naphthylethylamine. High purity, cost-effective Raney Nickel catalyst. Reliable supply chain for pharmaceutical intermediates.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN110835639B reveals a high-efficiency enzymatic route for producing chiral tetrahydroisoquinoline intermediates with superior stereoselectivity and scalable manufacturing potential.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Patent CN101622239A reveals a high-yield resolution method for homocysteine-gamma-thiolactone using chiral acids and aromatic aldehydes, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106397117A details a novel enzymatic resolution process yielding high-purity chiral alcohols with significant supply chain and cost advantages for global buyers.
Patent CN111500652A reveals a novel enzymatic dynamic kinetic resolution for florfenicol. Discover cost-effective, high-purity veterinary drug intermediate manufacturing solutions.
Patent CN104263798A details high-purity S-1-aminotetralin production via dynamic kinetic resolution offering significant supply chain and cost advantages.
Patent CN105087744A details DKR method for high-purity S-5-methyl-1-amino indan. Offers cost reduction in pharma manufacturing and supply chain reliability.
Patent CN106397391A reveals efficient DKR synthesis for chiral alcohols offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel enzymatic resolution process ensures greater than 99 percent ee value. Cost-effective Raney nickel catalyst reduces manufacturing expenses for reliable supply chain partners.
Patent CN107827890A reveals dynamic kinetic resolution for high-purity chiral purine acyclic nucleosides offering supply chain reliability and cost reduction.
Advanced patent CN104151352A details high-purity Sofosbuvir intermediate preparation via dynamic kinetic resolution ensuring supply chain reliability and cost efficiency.
Patent CN104178548A details high-purity S-2-naphthylethylamine synthesis via lipase. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel dynamic kinetic resolution method for R-2-naphthylethylamine. High yield, 99% ee. Cost-effective nickel catalyst. Reliable supply chain partner.